Silvia Noiman

Director/Board Member at

Vico Therapeutics BV

70 year

14 connections

Health Technology

Consumer Services

Finance

Profile

Silvia Noiman is the founder.
Founded Predix Pharmaceuticals Holdings, Inc. in 2000 as Senior Vice President.
Founded Imel Biotherapeutics, Inc. in 2019 as Chief Executive Officer.
Founded cCAM Biotherapeutics Ltd. in 2010 as Executive Chairman.
Founded Eloxx Pharmaceuticals Ltd. in 2013 as Chief Executive Officer & Director.
Founded Eloxx Pharmaceuticals, Inc. in 2017 as Director.
Dr. Noiman is also the founder of Predix Pharmaceuticals Ltd. Current job at Vico Therapeutics BV as Director since 2020.
Former job at Quiet Therapeutics Ltd. as Executive Chairman from 2010 to 2015.
Former job at Pontifax Management Co. Ltd. as Venture Partner.
Education at Tel-Aviv University with a doctorate degree.

Silvia Noiman active positions

Companies	Position	Start
Vico Therapeutics BV Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies	Director/Board Member	29/07/2020

All active positions of Silvia Noiman

Former positions of Silvia Noiman

Companies	Position	End
Imel Biotherapeutics, Inc. Imel Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for mitochondrial disease	Chief Executive Officer	01/04/2024
ELOXX PHARMACEUTICALS, INC.	Founder	01/04/2021
cCAM Biotherapeutics Ltd. cCAM Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets novel immunotherapy to treat cancer	Founder	01/07/2015
Predix Pharmaceuticals Holdings, Inc. Predix Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Discovers and developes novel, highly selective, small-molecule drugs	Founder	-
Pontifax Management Co. Ltd. Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax invests in companies located in Israel. The firm focuses on the companies operating in the fields of life sciences & health sector. The firm provide financing for early and growth stage capital transactions.	Private Equity Investor	-

See the detail of Silvia Noiman's experience

Training of Silvia Noiman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Silvia Noiman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Tel-Aviv University Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Predix Pharmaceuticals Holdings, Inc. Predix Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Discovers and developes novel, highly selective, small-molecule drugs	Health Technology
Predix Pharmaceuticals Ltd.
Pontifax Management Co. Ltd. Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax invests in companies located in Israel. The firm focuses on the companies operating in the fields of life sciences & health sector. The firm provide financing for early and growth stage capital transactions.	Finance
cCAM Biotherapeutics Ltd. cCAM Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets novel immunotherapy to treat cancer	Health Technology
Quiet Therapeutics Ltd. Quiet Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs	Health Technology
Eloxx Pharmaceuticals Ltd. Eloxx Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel genetic therapies	Health Technology
Eloxx Pharmaceuticals, Inc. Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases	Health Technology
Vico Therapeutics BV Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies	Health Technology
Imel Biotherapeutics, Inc. Imel Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for mitochondrial disease	Commercial Services